AU5716400A - Test animal for atherosclerosis model and methods for testing and screening - Google Patents

Test animal for atherosclerosis model and methods for testing and screening

Info

Publication number
AU5716400A
AU5716400A AU57164/00A AU5716400A AU5716400A AU 5716400 A AU5716400 A AU 5716400A AU 57164/00 A AU57164/00 A AU 57164/00A AU 5716400 A AU5716400 A AU 5716400A AU 5716400 A AU5716400 A AU 5716400A
Authority
AU
Australia
Prior art keywords
screening
testing
methods
test animal
atherosclerosis model
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57164/00A
Inventor
Jan-Willem Henricus Pieter Lardenoije
Paulus Hubertus Andreas Quax
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Original Assignee
Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO filed Critical Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Publication of AU5716400A publication Critical patent/AU5716400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0362—Animal model for lipid/glucose metabolism, e.g. obesity, type-2 diabetes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0375—Animal model for cardiovascular diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU57164/00A 1999-06-24 2000-06-23 Test animal for atherosclerosis model and methods for testing and screening Abandoned AU5716400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99202051 1999-06-24
EP99202051 1999-06-24
PCT/NL2000/000440 WO2001000014A2 (en) 1999-06-24 2000-06-23 Test animal for atherosclerosis model and methods for testing and screening

Publications (1)

Publication Number Publication Date
AU5716400A true AU5716400A (en) 2001-01-31

Family

ID=8240358

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57164/00A Abandoned AU5716400A (en) 1999-06-24 2000-06-23 Test animal for atherosclerosis model and methods for testing and screening

Country Status (3)

Country Link
EP (1) EP1185651A2 (en)
AU (1) AU5716400A (en)
WO (1) WO2001000014A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110313446A (en) * 2019-08-11 2019-10-11 江苏珂玛麒生物科技有限公司 A kind of non-human primate model of hypercholesterolemia high in fat, construction method and application
CN114271234B (en) * 2021-11-30 2022-11-29 西安医学院 Mouse model for simple hypercholesterolemia and atherosclerosis and construction method thereof
CN114557316B (en) * 2022-03-22 2023-05-16 西安交通大学 Method for constructing non-human primate coronary atherosclerosis model
CN115119800B (en) * 2022-07-01 2023-11-10 上海交通大学医学院附属第九人民医院 Application of reagent in preparation of mouse atherosclerosis inducer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767337A (en) * 1995-07-31 1998-06-16 Duke University Creation of human apolipoprotein E isoform specific transgenic mice in apolipoprotein deficient "knockout" mice
US6310270B1 (en) * 1996-03-15 2001-10-30 The General Hospital Corporation Endothelial NOS knockout mice and methods of use

Also Published As

Publication number Publication date
WO2001000014A2 (en) 2001-01-04
WO2001000014A3 (en) 2001-12-27
EP1185651A2 (en) 2002-03-13

Similar Documents

Publication Publication Date Title
AU5139900A (en) Liposome-enhanced test device and method
IL140389A0 (en) Methods for testing biological network models
AU5878000A (en) Device and method for assessing cardiovascular function
AU2387700A (en) Cause effect diagram program maintenance development and test system
AU5175600A (en) An improved simulation method and apparatus
GB2349270B (en) Mass analysis apparatus and method for mass analysis
WO2002077813A8 (en) Development and testing system and method
GB9915842D0 (en) Methods and apparatus for analysing a signal
AU4478600A (en) Method and apparatus for testing a well
AU3267999A (en) Nqr testing method and apparatus
AU7867600A (en) Methods and apparatus for cell analysis
AU1991201A (en) Testing system and method for testing an object
EP1167964A4 (en) Method and apparatus for non destructive testing
AU2889299A (en) Formation testing apparatus and method
EP1182967A4 (en) Method and apparatus for evaluating myoelectric signals and identifying artifact
AU3175200A (en) Method and apparatus for automated software testing
AU5603400A (en) Device and method for testing tissue
AU3634201A (en) Methods and devices for evaluating fatigue damage
TWI315459B (en) System and methods for configuring an automatic test system
GB2358280B (en) Mass analysis apparatus and method for mass analysis
AUPP422798A0 (en) Method and device for assessing cattle
AU5716400A (en) Test animal for atherosclerosis model and methods for testing and screening
GB9825624D0 (en) Model test apparatus and method
AU6215200A (en) Method and apparatus for testing magnetic head elements
AU2235501A (en) Method for testing an anemometer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase